0.18799999 EUR
0.004
2.17%
Last update Dec 12, 9:35 PM CET
Main market
Day range
0.18300000
0.18799999
Previous close
0.18400000
Open
0.18300000
Access this stock data via API
Subscribe
Northwest Biotherapeutics Inc.
0.19
0.00
2.17%

Financials

Income statement

Fundamentals currency is USD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 170.4K 111.6K 319.4K 196.8K
Cost of revenue
Gross profit
Operating expense
Research & development 6.3M 6.3M 7.1M 9.0M
Selling general and admin 6.0M 6.4M 8.0M 7.0M
Other operating expenses
Operating income -12.2M -12.6M -14.7M -15.8M
Non operating interest income
Income
Expense 2.2M 1.6M 1.4M 2.1M
Other income expense -8.4M 1.0M -366.3K -6.2M
Pretax income -22.9M -13.1M -16.5M -24.0M
Tax provision
Net income -22.9M -13.1M -16.5M -24.0M
Basic EPS 0.0 0.0 0.0
Diluted EPS 0.0 0.0 0.0
Basic average shares 1.3B 1.2B 1.2B
Diluted average shares 1.3B 1.2B 1.2B
EBITDA -13.1M -13.0M -14.3M -16.0M
Net income from continuing op. -22.9M -13.1M -16.5M -24.0M
Minority interests
Preferred stock dividends 300.7K 477.0K 225.7K 232.5K
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 10 hours 41 minutes

11:19
00:00
08:00
22:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 22:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).